ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 386 filers reported holding ENCOMPASS HEALTH CORP in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $98,174 | -6.9% | 1,815 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $105,399 | -23.1% | 1,762 | +0.8% | 0.00% | -25.0% |
| Q2 2021 | $137,000 | 0.0% | 1,748 | +5.8% | 0.00% | -20.0% |
| Q4 2020 | $137,000 | +17.1% | 1,652 | -7.9% | 0.01% | -16.7% |
| Q3 2020 | $117,000 | +9.3% | 1,794 | +7.7% | 0.01% | -14.3% |
| Q1 2020 | $107,000 | -7.0% | 1,665 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $115,000 | +0.9% | 1,665 | -7.2% | 0.01% | -14.3% |
| Q3 2019 | $114,000 | 0.0% | 1,795 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $114,000 | +26.7% | 1,795 | +16.9% | 0.01% | +16.7% |
| Q1 2019 | $90,000 | -54.8% | 1,535 | -52.4% | 0.01% | -64.7% |
| Q4 2018 | $199,000 | +47.4% | 3,226 | +85.9% | 0.02% | +70.0% |
| Q3 2018 | $135,000 | +3.1% | 1,735 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $131,000 | +32.3% | 1,735 | +0.6% | 0.01% | +25.0% |
| Q1 2018 | $99,000 | +16.5% | 1,725 | 0.0% | 0.01% | +14.3% |
| Q4 2017 | $85,000 | – | 1,725 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |